Skip to main content
Ahmed Osman, MD, Cardiology, Fort Lauderdale, FL, Broward Health Imperial Point

AhmedFOsmanMD

Cardiology Fort Lauderdale, FL

Cardiac Electrophysiology, Echocardiography, Cardiovascular Disease Genetics

Founder, Florida heart rhythm specialists, pllc

Dr. Osman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Osman's full profile

Already have an account?

Education & Training

  • University of Maryland
    University of MarylandFellowship, Clinical Cardiac Electrophysiology, 2000 - 2001
  • Ochsner Clinic Foundation
    Ochsner Clinic FoundationFellowship, Cardiovascular Disease, 1997 - 2000
  • Norwalk Hospital/Yale University
    Norwalk Hospital/Yale UniversityResidency, Internal Medicine, 1994 - 1997
  • Cairo University School of Medicine
    Cairo University School of MedicineClass of 1991

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2004 - 2026
  • LA State Medical License
    LA State Medical License 1997 - 2005
  • CT State Medical License
    CT State Medical License 1997 - 1997
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Clinical Cardiac Electrophysiology

Awards, Honors, & Recognition

  • Gulfstream FL-Broward Castle Connolly, 2011-2013
  • Top Doctors:South Florida Castle Connolly, 2012
  • CMS Meaningful Use Stage 1 Certification PrognoCIS EHR, Bizmatics, 2011-2012
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Robotic Electrophysiology Programme Opens in South Eastern USA
    Robotic Electrophysiology Programme Opens in South Eastern USAMarch 20th, 2023
  • Broward Health’s Commitment to Advanced Heart Care
    Broward Health’s Commitment to Advanced Heart CareJanuary 26th, 2022
  • PREFECT Trial Outcomes Demonstrate MyoStrain® Ability to Detect & Predict Early Cardiotoxicity in Cancer Patients Undergoing Chemotherapy
    PREFECT Trial Outcomes Demonstrate MyoStrain® Ability to Detect & Predict Early Cardiotoxicity in Cancer Patients Undergoing ChemotherapyJune 23rd, 2021
  • Join now to see all

Professional Memberships

Hospital Affiliations